Allogene Therapeutics (NASDAQ:ALLO) outlined upcoming milestones for its allogeneic CAR-T portfolio at TD Cowen’s 46th Annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results